Intrinsiqs

Is Crescent Biopharma, Inc. overvalued?

Crescent Biopharma, Inc. (CBIO) — key valuation metrics and fundamentals.

No verdict
Price
$18.07
Fair value
Current P/E
Normal P/E
Market cap
$497.1M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares CBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.